mDataType,dataset_name,drug_name,sens_stat,estimate,pvalue,drug_id,tissue mRNA,CTRPv2,1S,3R-RSL-3,AAC,-0.21359549402553,1.18618380356749e-10,4,pan-cancer mRNA,CTRPv2,ML162,AAC,-0.20768692862533,7.5118362294923e-10,453,pan-cancer mRNA,CCLE,paclitaxel,AAC,0.23584836360179,7.92968030227948e-08,526,pan-cancer mRNA,CTRPv2,ML210,AAC,-0.169820991276511,2.52143408740125e-07,455,pan-cancer mRNA,CTRPv2,tanespimycin:bortezomib (250:1 mol/mol),AAC,0.189705532793834,4.46692495931994e-07,675,pan-cancer mRNA,CTRPv2,Mitomycin-C,AAC,0.159855136865372,1.71926854618457e-06,445,pan-cancer mRNA,CTRPv2,3-Cl-AHPC,AAC,0.159184594075396,2.83289566618122e-06,5,pan-cancer mRNA,CTRPv2,CD-437,AAC,0.150156512317577,3.60533505007555e-06,209,pan-cancer mRNA,CTRPv2,nakiterpiosin,AAC,0.15040577112171,6.5553908159543e-06,473,pan-cancer mRNA,CTRPv2,SCH-79797,AAC,0.154511168098182,1.33356494789052e-05,617,pan-cancer mRNA,CTRPv2,selumetinib:vorinostat (8:1 mol/mol),AAC,0.156021369958777,2.36082673329442e-05,628,pan-cancer mRNA,CTRPv2,Dasatinib,AAC,-0.146971813960686,5.49378845623329e-05,262,pan-cancer mRNA,CTRPv2,5-FU,AAC,0.137987065154176,5.76537672879215e-05,7,pan-cancer mRNA,CTRPv2,FQI-2,AAC,0.130741283045278,5.79852255378481e-05,303,pan-cancer mRNA,CTRPv2,tanespimycin:gemcitabine (1:1 mol/mol),AAC,0.128178874992856,8.30751937152312e-05,676,pan-cancer mRNA,CCLE,17-AAG,AAC,0.179477246829067,8.38495499295769e-05,3,pan-cancer mRNA,CTRPv2,Cytarabine,AAC,0.110864894387567,0.000104745762056818,257,pan-cancer mRNA,CTRPv2,BRD-K70511574,AAC,0.123808310722736,0.000132736911993587,157,pan-cancer mRNA,CTRPv2,Gemcitabine,AAC,0.127457851408537,0.000135644111263212,316,pan-cancer mRNA,CTRPv2,BI-2536,AAC,0.119890954221438,0.000159454865213645,74,pan-cancer mRNA,CTRPv2,navitoclax:gemcitabine (1:1 mol/mol),AAC,0.128281657046634,0.000165872774967705,476,pan-cancer mRNA,CTRPv2,SB-743921,AAC,0.123862400453832,0.000169931166075507,613,pan-cancer mRNA,CTRPv2,GW843682X,AAC,0.130460303322766,0.000200871326373471,345,pan-cancer mRNA,CTRPv2,ML311,AAC,0.118667662981846,0.000279681415666394,458,pan-cancer mRNA,CTRPv2,isoevodiamine,AAC,0.117109463148131,0.000370818804015527,368,pan-cancer mRNA,CTRPv2,Repligen 136,AAC,0.131824072473274,0.0004110886288742,594,pan-cancer mRNA,CTRPv2,YK 4-279,AAC,0.113356381251119,0.000434081039535623,750,pan-cancer mRNA,CTRPv2,selumetinib:JQ-1 (4:1 mol/mol),AAC,0.121494956819591,0.000460381912870573,621,pan-cancer mRNA,CTRPv2,alisertib:navitoclax (2:1 mol/mol),AAC,0.122294985860338,0.000529145596867985,28,pan-cancer mRNA,CTRPv2,ceranib-2,AAC,0.114666006991245,0.00054016538613079,212,pan-cancer mRNA,GDSC1000,QL-VIII-58,AAC,-0.157101390412239,0.000669600649629139,581,pan-cancer mRNA,CTRPv2,GW-405833,AAC,0.117277244912386,0.000690126025528282,344,pan-cancer mRNA,CTRPv2,SU11274,AAC,0.120537814285348,0.000705576665143646,662,pan-cancer mRNA,CTRPv2,Compound 23 citrate,AAC,0.115127214146784,0.000761080406177832,243,pan-cancer mRNA,CTRPv2,doxorubicin:navitoclax (2:1 mol/mol),AAC,0.110516026199034,0.000762139765197289,274,pan-cancer mRNA,CTRPv2,BRD-K28456706,AAC,0.123794409047871,0.000783298869268301,125,pan-cancer mRNA,CTRPv2,vorinostat:carboplatin (1:1 mol/mol),AAC,0.114310850545525,0.000821745361567452,726,pan-cancer mRNA,CTRPv2,JQ-1,AAC,0.105239348139436,0.000911566740553092,382,pan-cancer mRNA,CTRPv2,KX2-391,AAC,0.107780024427066,0.000935811492512809,412,pan-cancer mRNA,CTRPv2,BRD9876,AAC,0.127636387758294,0.000945618728564613,184,pan-cancer mRNA,CTRPv2,paclitaxel,AAC,0.110392205761135,0.000946989916542372,526,pan-cancer mRNA,CTRPv2,Oxaliplatin,AAC,0.108703322945093,0.00104502071205756,523,pan-cancer mRNA,CTRPv2,BRD-K66453893,AAC,0.103117202193258,0.00113198899348585,155,pan-cancer mRNA,CTRPv2,GSK461364,AAC,0.103143873620697,0.00130037691640613,338,pan-cancer mRNA,CTRPv2,vincristine,AAC,0.0984378197838649,0.00136737546156918,721,pan-cancer mRNA,CTRPv2,marinopyrrole A,AAC,0.14356934248485,0.00148582177438105,433,pan-cancer mRNA,CTRPv2,clofarabine,AAC,0.0931086516814818,0.00150085068191017,238,pan-cancer mRNA,CTRPv2,avicin D,AAC,-0.17216939337638,0.00158197215343457,45,pan-cancer mRNA,CTRPv2,selumetinib:navitoclax (8:1 mol/mol),AAC,0.11664974296581,0.00174131547337784,623,pan-cancer mRNA,CTRPv2,BRD-K55116708,AAC,0.115797852516908,0.00174554945332451,149,pan-cancer mRNA,CTRPv2,PHA-793887,AAC,0.0990541805342775,0.00179018565129039,555,pan-cancer mRNA,CTRPv2,CI-976,AAC,0.121875108510653,0.00194936309525724,227,pan-cancer mRNA,CTRPv2,etoposide,AAC,0.0920266952864251,0.00209024819990746,290,pan-cancer mRNA,CTRPv2,darinaparsin,AAC,0.158864527129214,0.00211206239828968,261,pan-cancer mRNA,GDSC1000,QL-X-138,AAC,-0.0946569431688407,0.00226436237408684,582,pan-cancer mRNA,GDSC1000,OSI-027,AAC,-0.0954145165496319,0.00236430133578993,518,pan-cancer mRNA,CTRPv2,OSI-930,AAC,0.111465414076698,0.00249603562350055,520,pan-cancer mRNA,CTRPv2,BRD-K41597374,AAC,0.106571282696033,0.00276432799490379,138,pan-cancer mRNA,CTRPv2,serdemetan:SCH-529074 (1:1 mol/mol),AAC,0.105546275746481,0.00281140344617259,631,pan-cancer mRNA,CTRPv2,BIBR-1532,AAC,0.110292531920127,0.00296418959431206,75,pan-cancer mRNA,CTRPv2,indisulam,AAC,0.0966285519401677,0.00297893600076011,363,pan-cancer mRNA,CTRPv2,AZ-3146,AAC,0.105168146759545,0.00314875949506681,48,pan-cancer mRNA,CTRPv2,Docetaxel,AAC,0.143501597835705,0.00320811728614642,271,pan-cancer mRNA,CTRPv2,MS-275,AAC,0.0959338881145144,0.00338008256009209,468,pan-cancer mRNA,CTRPv2,erastin,AAC,-0.102810317277152,0.00367855987308332,284,pan-cancer mRNA,CTRPv2,MLN4924,AAC,0.0998999418822706,0.00369242091377337,464,pan-cancer mRNA,GDSC1000,pac-1,AAC,-0.103814968164488,0.00421910827736482,525,pan-cancer mRNA,CTRPv2,parbendazole,AAC,0.089578036819086,0.00428622197894977,530,pan-cancer mRNA,CTRPv2,Vorinostat,AAC,0.0951805313606146,0.00431933506133691,725,pan-cancer mRNA,GDSC1000,GSK-1904529A,AAC,-0.0964723080160224,0.00445956601552552,322,pan-cancer mRNA,CTRPv2,AZD6244,AAC,0.10200184529439,0.0046823832834375,56,pan-cancer mRNA,CTRPv2,prochlorperazine,AAC,0.105190086273853,0.00479117590701361,574,pan-cancer mRNA,CTRPv2,regorafenib,AAC,0.105016010988364,0.00558229269056238,593,pan-cancer mRNA,CTRPv2,ABT-737,AAC,0.100763603144813,0.0064371029447933,17,pan-cancer mRNA,CTRPv2,JQ-1:MK-0752 (1:1 mol/mol),AAC,0.0932943176123702,0.00649942474372199,384,pan-cancer mRNA,CTRPv2,Ko-143,AAC,0.101228744564015,0.00661733594949039,405,pan-cancer mRNA,CTRPv2,BRD9876:MK-1775 (4:1 mol/mol),AAC,0.316017789170435,0.0066811887854746,185,pan-cancer mRNA,CTRPv2,docetaxel:tanespimycin (2:1 mol/mol),AAC,0.0880288297116759,0.00741322323838591,272,pan-cancer mRNA,CTRPv2,Nutlin-3,AAC,0.0929046324701947,0.00745883538876994,507,pan-cancer mRNA,CTRPv2,Methotrexate,AAC,0.0993071370158123,0.00775541677113703,438,pan-cancer mRNA,CTRPv2,BRD1835,AAC,0.101870127208555,0.00784589493430576,178,pan-cancer mRNA,CTRPv2,KW-2449,AAC,0.0804961476505155,0.00846922214295411,411,pan-cancer mRNA,CTRPv2,Mdivi-1,AAC,0.0973915910857672,0.00847520038497064,435,pan-cancer mRNA,CTRPv2,ELCPK,AAC,0.131899654103665,0.00868908109634781,277,pan-cancer mRNA,CTRPv2,GSK-J4,AAC,0.275423216705417,0.00918035847956355,325,pan-cancer mRNA,CTRPv2,FQI-1,AAC,0.123080795038511,0.00920520115976482,302,pan-cancer mRNA,CTRPv2,salermide:PLX-4032 (12:1 mol/mol),AAC,0.0981397133188444,0.00942992748736606,605,pan-cancer mRNA,CTRPv2,hyperforin,AAC,0.101732432521902,0.00970419782594603,352,pan-cancer mRNA,CTRPv2,RITA,AAC,0.0928457972875476,0.0099339702175818,597,pan-cancer mRNA,CTRPv2,austocystin d,AAC,0.0966353461096258,0.0102063302363184,43,pan-cancer mRNA,CTRPv2,SB-225002,AAC,0.0800960757873804,0.0103970183065721,609,pan-cancer mRNA,CTRPv2,NVP-231,AAC,0.0840041749139507,0.0104049585853613,509,pan-cancer mRNA,CTRPv2,triazolothiadiazine,AAC,0.0772996562038312,0.0104294821213738,702,pan-cancer mRNA,CTRPv2,COL-3,AAC,0.0970026905768182,0.0104546737247104,240,pan-cancer mRNA,GDSC1000,JW-7-24-1,AAC,-0.0758158541579162,0.0111977599033919,391,pan-cancer mRNA,CTRPv2,CHEMBL1222381,AAC,0.0854631510064201,0.0112039500254213,221,pan-cancer mRNA,CTRPv2,GDC-0879,AAC,0.0903918192962356,0.0112658503384571,312,pan-cancer mRNA,CTRPv2,BRD-K80183349,AAC,0.0827315540485296,0.0119744661676308,163,pan-cancer mRNA,CTRPv2,GSK525762A,AAC,0.0753828603289191,0.0123351016064422,339,pan-cancer mRNA,CTRPv2,BRD-K88742110,AAC,0.0919946253784849,0.0123516203852059,167,pan-cancer mRNA,CTRPv2,JQ-1:carboplatin (1:1 mol/mol),AAC,0.0823480121339873,0.0124227991806693,383,pan-cancer mRNA,GDSC1000,17-AAG,AAC,0.0808942979790329,0.0124458609648981,3,pan-cancer mRNA,CTRPv2,ciclosporin,AAC,0.0943799514945481,0.0131148909713412,229,pan-cancer mRNA,CTRPv2,Carboplatin,AAC,0.0904277637042711,0.0135023566878652,197,pan-cancer mRNA,CTRPv2,ISOX:bortezomib (250:1 mol/mol),AAC,0.087549864389185,0.0135263976683954,372,pan-cancer mRNA,CTRPv2,PF-573228,AAC,0.0847575556112459,0.0135496320011324,551,pan-cancer mRNA,CTRPv2,CHM-1,AAC,0.0805678460785433,0.0139336690886011,225,pan-cancer mRNA,GDSC1000,EKB-569,AAC,-0.080731403122901,0.0147381936819513,276,pan-cancer mRNA,CTRPv2,rigosertib,AAC,0.0808937457203408,0.0148447848633766,596,pan-cancer mRNA,CTRPv2,selumetinib:decitabine (4:1 mol/mol),AAC,0.083053138062556,0.014896676540164,619,pan-cancer mRNA,CTRPv2,Topotecan,AAC,0.0783600738138247,0.0149159062844232,697,pan-cancer mRNA,CTRPv2,Doxorubicin,AAC,0.0735543460193734,0.0150476455308416,273,pan-cancer mRNA,CTRPv2,carboplatin:etoposide (40:17 mol/mol),AAC,0.072428995594588,0.0156743414931595,198,pan-cancer mRNA,CTRPv2,KU 0060648,AAC,0.0863683555845485,0.016297014383032,407,pan-cancer mRNA,CTRPv2,BMS-345541,AAC,0.0875881789607511,0.0169461449841422,87,pan-cancer mRNA,CTRPv2,linifanib,AAC,0.086367463570538,0.0169547554022158,424,pan-cancer mRNA,CTRPv2,tivantinib,AAC,0.107105104538917,0.0174144300733567,692,pan-cancer mRNA,CTRPv2,leptomycin B,AAC,0.0807438203128822,0.017527559717699,421,pan-cancer mRNA,CTRPv2,manumycin A,AAC,0.0767703293356974,0.0179165098400282,432,pan-cancer mRNA,CCLE,Topotecan,AAC,0.0997791230823215,0.0180548704750144,697,pan-cancer mRNA,CTRPv2,NVP-ADW742,AAC,0.0829835979582491,0.0192014019098856,510,pan-cancer mRNA,CTRPv2,LE-135,AAC,0.0854524436736622,0.019963801550472,418,pan-cancer mRNA,CTRPv2,silmitasertib,AAC,0.0903838812762982,0.0202776898549259,638,pan-cancer mRNA,CTRPv2,LY-2183240,AAC,0.0743158480330221,0.0205679745706085,430,pan-cancer mRNA,CTRPv2,SR-II-138A,AAC,0.0737838195551948,0.020654629539594,654,pan-cancer mRNA,CTRPv2,SB-525334,AAC,0.0862464277290865,0.0209465163106347,612,pan-cancer mRNA,CTRPv2,gossypol,AAC,0.086216122722749,0.0217081829447499,321,pan-cancer mRNA,CTRPv2,tacrolimus,AAC,0.0820513367878741,0.0219426587622931,668,pan-cancer mRNA,CTRPv2,navitoclax:birinapant (1:1 mol/mol),AAC,0.0835038798300474,0.0225546758551418,475,pan-cancer mRNA,CTRPv2,BMS-754807,AAC,0.0794821468470753,0.0230642879577243,91,pan-cancer mRNA,CTRPv2,pifithrin-alpha,AAC,0.0851630226159021,0.0237114506812858,559,pan-cancer mRNA,GDSC1000,WZ-1-84,AAC,-0.115534663295114,0.0237654786888623,735,pan-cancer mRNA,GDSC1000,ZSTK474,AAC,-0.0703694660440552,0.0244617797943686,759,pan-cancer mRNA,CTRPv2,SNX-2112:bortezomib (250:1 mol/mol),AAC,0.0741885881256088,0.024586117799357,650,pan-cancer mRNA,CTRPv2,BRD-K29313308,AAC,0.0839340607459888,0.0247990486263544,127,pan-cancer mRNA,CTRPv2,BRD-K61166597,AAC,0.071787249220886,0.0256483875479933,152,pan-cancer mRNA,CTRPv2,VAF-347,AAC,0.105339302616814,0.0258238101946901,714,pan-cancer mRNA,CTRPv2,decitabine:navitoclax (2:1 mol/mol),AAC,0.0706427557347494,0.0259134362639445,266,pan-cancer mRNA,CTRPv2,CD-1530,AAC,0.0863766534933679,0.0260140136769762,208,pan-cancer mRNA,CTRPv2,selumetinib:GDC-0941 (4:1 mol/mol),AAC,0.0791243600419764,0.0286815758392588,620,pan-cancer mRNA,CTRPv2,KHS101,AAC,0.0817520793586565,0.0288937640233181,395,pan-cancer mRNA,GDSC1000,T0901317,AAC,-0.0728310908082657,0.0294629883748896,666,pan-cancer mRNA,CTRPv2,selumetinib:tretinoin (2:1 mol/mol),AAC,0.07812011567328,0.0299353825658715,626,pan-cancer mRNA,CTRPv2,GSK4112,AAC,0.0809064188859522,0.0304874201864812,336,pan-cancer mRNA,CTRPv2,Gefitinib,AAC,0.079626146912358,0.0310719477601933,314,pan-cancer mRNA,GDSC1000,CP466722,AAC,-0.064240740983013,0.0325087176631278,245,pan-cancer mRNA,CTRPv2,ISOX,AAC,0.0684947264895206,0.0334478881034172,371,pan-cancer mRNA,CTRPv2,dinaciclib,AAC,0.103522840385619,0.0335962092440209,268,pan-cancer mRNA,GDSC1000,Nutlin-3a (-),AAC,-0.0731196636379117,0.0339936140913673,508,pan-cancer mRNA,CTRPv2,StemRegenin 1,AAC,0.074515086066211,0.0340832401193457,659,pan-cancer mRNA,CTRPv2,NSC632839,AAC,0.0724393670700714,0.0343530627232216,502,pan-cancer mRNA,CTRPv2,decitabine:carboplatin (1:1 mol/mol),AAC,0.0604875737310847,0.0353679452447512,265,pan-cancer mRNA,CTRPv2,AGK-2,AAC,0.080349986894431,0.0354901519053102,24,pan-cancer mRNA,CTRPv2,PF-184,AAC,0.070624095310586,0.0360232699915037,542,pan-cancer mRNA,GDSC1000,GSK2126458,AAC,-0.0672361406559925,0.036046246874222,332,pan-cancer mRNA,CTRPv2,lapatinib,AAC,0.0760448370363307,0.0365264841178559,415,pan-cancer mRNA,CTRPv2,N9-isopropylolomoucine,AAC,0.0756481677906635,0.038833016984517,472,pan-cancer mRNA,CTRPv2,AZD0530,AAC,-0.0757332121172665,0.0400124632973798,53,pan-cancer mRNA,GDSC1000,HG-6-64-1,AAC,-0.0704760785959181,0.0401343613897952,350,pan-cancer mRNA,GDSC1000,Mitomycin-C,AAC,0.0725144959433245,0.0416203540599183,445,pan-cancer mRNA,CTRPv2,OSI-906,AAC,0.0729158716264538,0.041621110806229,519,pan-cancer mRNA,CTRPv2,SCH-529074,AAC,0.0777148128634966,0.0430692250721619,616,pan-cancer mRNA,CTRPv2,CHEMBL374350,AAC,0.0775280120480341,0.0438337006428315,222,pan-cancer mRNA,CTRPv2,B02,AAC,0.0737503478556974,0.0446036667352588,60,pan-cancer mRNA,CTRPv2,JQ-1:navitoclax (2:1 mol/mol),AAC,0.0690577030144336,0.0446144169224837,385,pan-cancer mRNA,GDSC1000,AICAR,AAC,0.0648925093509452,0.0448721445906714,25,pan-cancer mRNA,UHNBreast,lapatinib,AAC,0.562961887963558,0.0451608388259764,415,pan-cancer mRNA,GDSC1000,PI-103,AAC,-0.0616014558050722,0.0455196662278627,558,pan-cancer mRNA,CTRPv2,pac-1,AAC,0.0725234087254701,0.0460350433532049,525,pan-cancer mRNA,CTRPv2,SZ4TA2,AAC,-0.108616434164444,0.0468454768541379,665,pan-cancer mRNA,GDSC1000,Cetuximab,AAC,0.0660470441658855,0.0473132967561912,214,pan-cancer mRNA,CTRPv2,tacedinaline,AAC,0.0753090552988223,0.0485878734098187,667,pan-cancer mRNA,GDSC1000,PHA-665752,AAC,0.101263854900604,0.0498472759707182,554,pan-cancer mRNA,CCLE,lapatinib,AAC,0.0859062413628433,0.0504528332678401,415,pan-cancer mRNA,CTRPv2,AT-406,AAC,0.0953124484759375,0.050739350052045,38,pan-cancer mRNA,GDSC1000,rTRAIL,AAC,0.0687926399344677,0.05212649941176,601,pan-cancer mRNA,CTRPv2,niclosamide,AAC,0.0707275130600871,0.0523638917446107,490,pan-cancer mRNA,CTRPv2,bafilomycin A1,AAC,0.261772821495129,0.0551947512784163,61,pan-cancer mRNA,CTRPv2,TPCA-1,AAC,0.0629317276216148,0.0552393424532204,699,pan-cancer mRNA,GDSC1000,QL-XII-47,AAC,-0.0628013185583826,0.0573430259292262,584,pan-cancer mRNA,CTRPv2,PF-3758309,AAC,0.0834325743763278,0.0575226322748904,544,pan-cancer mRNA,CTRPv2,cediranib,AAC,-0.102213560520036,0.0580636842139136,210,pan-cancer mRNA,GDSC1000,A-443654,AAC,-0.0980487788513402,0.0591165209309763,10,pan-cancer mRNA,GDSC1000,BMS-708163,AAC,-0.0634748387849078,0.0616464356115406,90,pan-cancer mRNA,CCLE,Irinotecan,AAC,0.100656459474057,0.0616474625512307,367,pan-cancer mRNA,GDSC1000,Sorafenib,AAC,0.100895888121083,0.0621409188096311,651,pan-cancer mRNA,CTRPv2,carboplatin:UNC0638 (2:1 mol/mol),AAC,0.0699852607022664,0.0650800028087909,199,pan-cancer mRNA,CTRPv2,cyanoquinoline 11,AAC,0.0955863483790884,0.0651868792270155,254,pan-cancer mRNA,GDSC1000,Gemcitabine,AAC,0.0650742277092107,0.0652395960739045,316,pan-cancer mRNA,GDSC1000,KIN001-102,AAC,-0.0554632437028111,0.0661335178232313,398,pan-cancer mRNA,CTRPv2,TAE684,AAC,0.0652124007146266,0.0662824649839088,669,pan-cancer mRNA,GDSC1000,BMS-509744,AAC,-0.0952472790373176,0.0670420683544404,88,pan-cancer mRNA,FIMM,Methotrexate,AAC,-0.267267108708452,0.068903243897037,438,pan-cancer mRNA,CTRPv2,JQ-1:vorinostat (2:1 mol/mol),AAC,0.0608266651262174,0.0693441394241427,387,pan-cancer mRNA,CTRPv2,AA-COCF3,AAC,0.0655161173679652,0.0693559553655652,13,pan-cancer mRNA,CTRPv2,Merck60,AAC,0.0553319168182334,0.0694679943251512,437,pan-cancer mRNA,CTRPv2,BRD-K50799972,AAC,0.0691733554400624,0.0701031648418924,145,pan-cancer mRNA,CTRPv2,IU1,AAC,0.0705231357462005,0.0709097386113887,377,pan-cancer mRNA,GDSC1000,Imatinib,AAC,0.096455927501593,0.0709763542084881,361,pan-cancer mRNA,CTRPv2,pluripotin,AAC,-0.0642882740148717,0.0717688227115418,567,pan-cancer mRNA,FIMM,paclitaxel,AAC,-0.269328862590136,0.0717970296744585,526,pan-cancer mRNA,CTRPv2,968,AAC,0.124320222768445,0.0718810890026818,9,pan-cancer mRNA,CTRPv2,16-beta-bromoandrosterone,AAC,0.0679275225118083,0.0732742032798733,2,pan-cancer mRNA,CTRPv2,BRD-K29086754,AAC,0.134546260385163,0.0739724543901464,126,pan-cancer mRNA,CTRPv2,JQ-1:UNC0638 (2:1 mol/mol),AAC,0.0616034575303858,0.0773478686317919,386,pan-cancer mRNA,CTRPv2,selumetinib:piperlongumine (8:1 mol/mol),AAC,0.063168066028079,0.0774308399453055,624,pan-cancer mRNA,CTRPv2,SMER-3,AAC,-0.0675937568874603,0.0783990626908751,646,pan-cancer mRNA,CTRPv2,ruxolitinib,AAC,0.0613526807160206,0.0796632109156947,602,pan-cancer mRNA,GDSC1000,CMK,AAC,-0.093248379749921,0.0800797973424277,239,pan-cancer mRNA,CTRPv2,AM-580,AAC,0.065980399402523,0.0803652414916986,30,pan-cancer mRNA,CTRPv2,BRD-K55473186,AAC,0.0825625254993849,0.0810753085829699,150,pan-cancer mRNA,CTRPv2,MK 1775,AAC,0.0596580469987926,0.0828439087978433,446,pan-cancer mRNA,CTRPv2,ABT-263,AAC,0.0621171558694949,0.0832341277534236,16,pan-cancer mRNA,CTRPv2,SN-38,AAC,0.0645383665266377,0.0843085590139077,647,pan-cancer mRNA,CTRPv2,ML006,AAC,0.0645739297400824,0.0853550228040929,449,pan-cancer mRNA,CTRPv2,narciclasine,AAC,0.0577548728579459,0.0854345618170626,474,pan-cancer mRNA,GDSC1000,thapsigargin,AAC,0.060919793645832,0.0856346304148618,686,pan-cancer mRNA,GDSC1000,TAK-715,AAC,-0.0564719790957895,0.085807303821665,670,pan-cancer mRNA,CTRPv2,thalidomide,AAC,-0.0918168012619741,0.0900388829733656,685,pan-cancer mRNA,GDSC1000,Nilotinib,AAC,0.0631270860640182,0.0912579266155507,491,pan-cancer mRNA,CTRPv2,ciclopirox,AAC,0.0557188482692598,0.0918612131942479,228,pan-cancer mRNA,CTRPv2,MI-1,AAC,0.0674957305864174,0.091988815139023,442,pan-cancer mRNA,CTRPv2,crizotinib:PLX-4032 (2:1 mol/mol),AAC,0.0586460065360715,0.0922103791433146,249,pan-cancer mRNA,CTRPv2,cimetidine,AAC,0.113999379355565,0.0929312701766086,236,pan-cancer mRNA,CTRPv2,PD318088,AAC,0.0590441758895494,0.0953201435729726,538,pan-cancer mRNA,CTRPv2,dacarbazine,AAC,0.053528463371412,0.0956587598030049,260,pan-cancer mRNA,GDSC1000,YK 4-279,AAC,0.0619183868791124,0.0958027253906535,750,pan-cancer mRNA,CTRPv2,Crizotinib,AAC,0.0542092868762959,0.0976118457749947,248,pan-cancer mRNA,CTRPv2,PDMP,AAC,0.0633093153610925,0.0989579471991718,540,pan-cancer mRNA,CTRPv2,alvocidib,AAC,0.0813795787521483,0.099009667141198,29,pan-cancer mRNA,GDSC1000,GSK-650394,AAC,0.0592177553417297,0.0992023923643643,324,pan-cancer mRNA,CTRPv2,vorinostat:navitoclax (4:1 mol/mol),AAC,0.0582637535100307,0.101377074817943,727,pan-cancer mRNA,GDSC1000,BMS-536924,AAC,-0.0537921184966081,0.101961918054509,89,pan-cancer mRNA,CTRPv2,decitabine,AAC,0.0455528703165256,0.102412874257529,264,pan-cancer mRNA,GDSC1000,BX-795,AAC,0.0564465842735969,0.102427108817095,189,pan-cancer mRNA,gCSI,Docetaxel,AAC,0.0866407971405005,0.102984445311105,271,pan-cancer mRNA,CTRPv2,necrostatin-7,AAC,0.061087610515303,0.104318266126807,483,pan-cancer mRNA,CCLE,PD-0325901,AAC,0.0676571237225031,0.106699348360321,535,pan-cancer mRNA,CTRPv2,myriocin,AAC,0.128940121427892,0.108368500336221,471,pan-cancer mRNA,CTRPv2,dexamethasone,AAC,0.054292537395556,0.10911773710894,267,pan-cancer mRNA,CTRPv2,I-BET151,AAC,0.0496641128846326,0.110990490015016,354,pan-cancer mRNA,GDSC1000,GSK690693,AAC,-0.0514405501628038,0.111247506940268,340,pan-cancer mRNA,FIMM,temsirolimus,AAC,-0.283602202018343,0.112683485012613,680,pan-cancer mRNA,GDSC1000,XMD8-85,AAC,0.0814933006106723,0.112788483465094,746,pan-cancer mRNA,UHNBreast,paclitaxel,AAC,0.480198478084596,0.114097737775244,526,pan-cancer mRNA,CTRPv2,BIX-01294,AAC,0.0548954343162703,0.114671217180309,81,pan-cancer mRNA,CTRPv2,BRD-K97651142,AAC,0.0599760673738623,0.115153704493519,173,pan-cancer mRNA,GDSC1000,AT-7519,AAC,-0.046985298402953,0.1154635455048,39,pan-cancer mRNA,FIMM,Vandetanib,AAC,-0.306072435268766,0.115688094518631,717,pan-cancer mRNA,CTRPv2,A-804598,AAC,-0.0727325470760482,0.117117587890361,12,pan-cancer mRNA,CTRPv2,BRD-K34099515,AAC,0.119762202848566,0.117889624814491,132,pan-cancer mRNA,FIMM,BI-2536,AAC,-0.222213407884625,0.118724603512637,74,pan-cancer mRNA,GDSC1000,CAL-101,AAC,-0.0497187713445082,0.119068581815178,194,pan-cancer mRNA,CCLE,L-685458,AAC,0.0695714052366551,0.121084817847612,413,pan-cancer mRNA,FIMM,Topotecan,AAC,-0.182684902380752,0.12141234711056,697,pan-cancer mRNA,CTRPv2,chlorambucil,AAC,0.049436198402107,0.122190354460432,224,pan-cancer mRNA,GDSC1000,AS605240,AAC,-0.05156635416419,0.12310712348835,37,pan-cancer mRNA,GDSC1000,Lisitinib,AAC,-0.0531111882822427,0.123508480128697,425,pan-cancer mRNA,FIMM,GDC-0941,AAC,-0.311934369825673,0.12352792737618,313,pan-cancer mRNA,CTRPv2,BRD-K27188169:navitoclax (2:1 mol/mol),AAC,0.0814726732542883,0.125496750188931,122,pan-cancer mRNA,CTRPv2,BRD-K02251932,AAC,0.0600857581714465,0.125522527365944,102,pan-cancer mRNA,CCLE,PD-0332991,AAC,0.072158124759884,0.125806500186132,536,pan-cancer mRNA,GDSC1000,AZD7762,AAC,0.0499276691362612,0.12950820772879,58,pan-cancer mRNA,GDSC1000,KIN001-236,AAC,-0.0511099309833807,0.130984887913666,400,pan-cancer mRNA,GDSC1000,Dasatinib,AAC,-0.0747906846078059,0.131228410126498,262,pan-cancer mRNA,GDSC1000,NSC-207895,AAC,0.0509060900759568,0.131485540931319,496,pan-cancer mRNA,GDSC1000,OSU-03012,AAC,-0.0523146059598569,0.131780920828996,521,pan-cancer mRNA,GDSC1000,WH-4-023,AAC,-0.0747145635545007,0.133820189243844,733,pan-cancer mRNA,CTRPv2,BRD8899,AAC,-0.0576267789947217,0.134141930852109,181,pan-cancer mRNA,GDSC1000,CGP-082996,AAC,-0.078067743692169,0.134214110626308,217,pan-cancer mRNA,CTRPv2,BMS-536924,AAC,0.0542330327803693,0.134542391955734,89,pan-cancer mRNA,CTRPv2,BRD-A02303741:navitoclax (2:1 mol/mol),AAC,0.0542384031030318,0.137321092087379,96,pan-cancer mRNA,GDSC1000,KU-55933,AAC,0.0531236612326358,0.138451818821345,409,pan-cancer mRNA,CCLE,LBW242,AAC,0.0696911195072112,0.139095441852045,417,pan-cancer mRNA,CTRPv2,BRD-K48477130,AAC,-0.0824724982222498,0.143040167218827,143,pan-cancer mRNA,CTRPv2,Bax channel blocker,AAC,0.056404824936784,0.144008549313307,65,pan-cancer mRNA,GDSC1000,PIK-93,AAC,-0.0422211053822303,0.146197048235593,561,pan-cancer mRNA,CTRPv2,ABT-199,AAC,0.0640295030274184,0.148518479959286,15,pan-cancer mRNA,CTRPv2,birinapant,AAC,0.0552887056787076,0.148702582481562,80,pan-cancer mRNA,CTRPv2,itraconazole,AAC,0.0556607422313637,0.150203938564679,376,pan-cancer mRNA,GDSC1000,Vinblastine,AAC,0.0494317618886727,0.152442181878495,720,pan-cancer mRNA,GDSC1000,AZ628,AAC,0.0694580321290208,0.155192428283078,49,pan-cancer mRNA,CTRPv2,Tamoxifen,AAC,0.0538679414695283,0.159023948405229,673,pan-cancer mRNA,GDSC1000,Crizotinib,AAC,0.0747852513483604,0.160309444094568,248,pan-cancer mRNA,GDSC1000,SNX-2112,AAC,0.0424432250303515,0.160406577183309,649,pan-cancer mRNA,CTRPv2,barasertib,AAC,0.0456565119887995,0.161021065625107,63,pan-cancer mRNA,CTRPv2,JW-480,AAC,0.0536260547877167,0.161325024882351,389,pan-cancer mRNA,CTRPv2,ZSTK474,AAC,0.0526306009197736,0.161369614730443,759,pan-cancer mRNA,CTRPv2,HC-067047,AAC,0.0536605126575182,0.162736830760509,347,pan-cancer mRNA,FIMM,MS-275,AAC,0.207084277483097,0.163286843020642,468,pan-cancer mRNA,GDSC1000,AZD6482,AAC,-0.0451553976822549,0.163344271078745,57,pan-cancer mRNA,CCLE,AZD6244,AAC,0.05997386621129,0.164450851480777,56,pan-cancer mRNA,CTRPv2,betulinic acid,AAC,0.0542853414676086,0.164482250312128,71,pan-cancer mRNA,CTRPv2,epigallocatechin-3-monogallate,AAC,-0.0508793395754505,0.164506023938137,281,pan-cancer mRNA,GDSC1000,Vorinostat,AAC,0.0434421340623813,0.166255548760844,725,pan-cancer mRNA,CTRPv2,salermide,AAC,0.0645286666209415,0.166340908612013,604,pan-cancer mRNA,CTRPv2,SNX-2112,AAC,0.0444715969506161,0.166385507245149,649,pan-cancer mRNA,CTRPv2,apicidin,AAC,0.0435097184972129,0.167143844733409,33,pan-cancer mRNA,CTRPv2,alisertib,AAC,0.0437910530092141,0.168429153968264,27,pan-cancer mRNA,CTRPv2,tosedostat,AAC,0.0507697731709411,0.168762401624651,698,pan-cancer mRNA,FIMM,RAF265,AAC,-0.265480239130102,0.172554397954899,590,pan-cancer mRNA,CTRPv2,Curcumin,AAC,0.0473801671010099,0.172727122210479,252,pan-cancer mRNA,CTRPv2,Compound 1541A,AAC,0.0532557380718407,0.175938698137812,241,pan-cancer mRNA,CTRPv2,AZD-2281,AAC,0.0473829018192281,0.17817959606673,51,pan-cancer mRNA,gCSI,paclitaxel,AAC,0.0704204063153703,0.178501508483861,526,pan-cancer mRNA,CTRPv2,avrainvillamide,AAC,0.0561107391720258,0.178544144336408,46,pan-cancer mRNA,CCLE,Panobinostat,AAC,0.0545102298283512,0.179859759623047,529,pan-cancer mRNA,CTRPv2,elocalcitol,AAC,0.0466969516679185,0.181097617006893,279,pan-cancer mRNA,CTRPv2,PI-103,AAC,-0.0473120741735353,0.181569937772771,558,pan-cancer mRNA,CTRPv2,HLI 373,AAC,0.0481275998334104,0.181974166348004,351,pan-cancer mRNA,CTRPv2,CBB-1007,AAC,-0.0728819649966109,0.183515224318334,204,pan-cancer mRNA,CTRPv2,BRD-A94377914,AAC,0.0581096859223347,0.187799624052469,100,pan-cancer mRNA,GDSC1000,BMS-754807,AAC,-0.0445451132395056,0.19056393787753,91,pan-cancer mRNA,GDSC1000,AG-014699,AAC,-0.044476038854054,0.193099775892151,22,pan-cancer mRNA,CTRPv2,CR-1-31B,AAC,0.0425656086879978,0.195129168783367,247,pan-cancer mRNA,CTRPv2,PF-543,AAC,0.0493778351041442,0.195362517670493,549,pan-cancer mRNA,CTRPv2,GSK2636771,AAC,-0.0562409183639386,0.198252304503928,334,pan-cancer mRNA,GDSC1000,CHIR-99021,AAC,-0.0412448168206603,0.198520716281133,223,pan-cancer mRNA,GDSC1000,A-770041,AAC,-0.0663211766307983,0.199292352656544,11,pan-cancer mRNA,GDSC1000,TG-101348,AAC,-0.0365584836771928,0.201804153525003,683,pan-cancer mRNA,CTRPv2,phloretin,AAC,0.0440941744277007,0.204881293505509,557,pan-cancer mRNA,CTRPv2,masitinib,AAC,0.0465194484734707,0.206726215345835,434,pan-cancer mRNA,GDSC1000,GSK1070916,AAC,0.0402372758812108,0.208051419519717,328,pan-cancer mRNA,FIMM,Cyclopamine,AAC,-0.208435777182793,0.208209744378372,255,pan-cancer mRNA,CCLE,TKI258,AAC,0.0577939189823517,0.208616507571371,694,pan-cancer mRNA,GDSC1000,Cytarabine,AAC,0.0450414958190047,0.208783762386923,257,pan-cancer mRNA,CTRPv2,selumetinib:UNC0638 (4:1 mol/mol),AAC,0.0444693068118834,0.212624581697769,627,pan-cancer mRNA,CTRPv2,L-685458,AAC,0.0463241236223357,0.21657258788082,413,pan-cancer mRNA,CTRPv2,BRD4132,AAC,0.0470744510215747,0.219928048384699,179,pan-cancer mRNA,GDSC1000,LFM-A13,AAC,-0.0430687091845378,0.220244072887079,423,pan-cancer mRNA,GDSC1000,BIX02189,AAC,-0.0387730666416108,0.22042031716884,82,pan-cancer mRNA,CTRPv2,RAF265,AAC,0.0503613999086368,0.220713700509442,590,pan-cancer mRNA,FIMM,BMS-754807,AAC,-0.179974954782476,0.222684765893578,91,pan-cancer mRNA,CCLE,PLX4720,AAC,0.0528188766374151,0.223672245854856,569,pan-cancer mRNA,CTRPv2,methylstat,AAC,-0.0514216783753739,0.224154828583718,439,pan-cancer mRNA,CTRPv2,AZD6482,AAC,-0.0450555856150944,0.225067932070522,57,pan-cancer mRNA,GDSC1000,EHT 1864,AAC,-0.0418472785559723,0.226878032014114,275,pan-cancer mRNA,FIMM,Epothilone B,AAC,-0.226401160644453,0.227653954468009,283,pan-cancer mRNA,CTRPv2,BRD-K33199242,AAC,0.0457100479152515,0.233494162462725,130,pan-cancer mRNA,CTRPv2,bendamustine,AAC,0.0449794604155665,0.236285297007022,70,pan-cancer mRNA,gCSI,Gemcitabine,AAC,0.0654383537824077,0.237056455671109,316,pan-cancer mRNA,FIMM,Irinotecan,AAC,-0.151033991414432,0.237866623632825,367,pan-cancer mRNA,CTRPv2,BRD-K11533227,AAC,0.0443420190183543,0.240248193940196,110,pan-cancer mRNA,CTRPv2,BRD-K64610608,AAC,0.0462183704668374,0.241436568477756,154,pan-cancer mRNA,CTRPv2,dabrafenib,AAC,0.0556973031938463,0.241779929998884,259,pan-cancer mRNA,CTRPv2,CIL56,AAC,-0.0542973140971808,0.242857567156262,234,pan-cancer mRNA,CTRPv2,BRD-K52037352,AAC,0.0479519412801009,0.245028333138108,148,pan-cancer mRNA,GDSC1000,Doxorubicin,AAC,-0.0413812783073021,0.248306259639989,273,pan-cancer mRNA,GDSC1000,GW 441756,AAC,0.0414043232990999,0.248794138932312,342,pan-cancer mRNA,GDSC1000,JNJ-26854165,AAC,0.0393253222644003,0.24909726297121,379,pan-cancer mRNA,GDSC1000,shikonin,AAC,-0.0397587546407378,0.24947969217398,634,pan-cancer mRNA,CTRPv2,tretinoin:carboplatin (2:1 mol/mol),AAC,0.0405363641427743,0.252074106995215,700,pan-cancer mRNA,GDSC1000,CGP-60474,AAC,-0.0585267906723743,0.256313198425806,218,pan-cancer mRNA,CTRPv2,Bosutinib,AAC,0.0398271988709132,0.257040785952209,93,pan-cancer mRNA,GDSC1000,Salubrinal,AAC,0.0594214175141387,0.257262276933755,606,pan-cancer mRNA,GDSC1000,Z-LLNle-CHO,AAC,0.0546955415282433,0.257450931400105,754,pan-cancer mRNA,gCSI,PD-0325901,AAC,0.0572281065223333,0.257953618352218,535,pan-cancer mRNA,CTRPv2,BRD-K66532283,AAC,0.0384817928937612,0.258204805266161,156,pan-cancer mRNA,GDSC1000,S-Trityl-L-cysteine,AAC,0.0581150611385097,0.258625142560853,603,pan-cancer mRNA,CTRPv2,Zebularine,AAC,0.0391859071013722,0.258814024865111,755,pan-cancer mRNA,CTRPv2,BRD-K37390332,AAC,-0.04440773454009,0.261339461608892,136,pan-cancer mRNA,CTRPv2,BMS-270394,AAC,-0.0419767404319304,0.26160389265237,86,pan-cancer mRNA,CTRPv2,PIK-93,AAC,0.0395962095822061,0.262554004907874,561,pan-cancer mRNA,CTRPv2,CAY10594,AAC,0.0427941982841794,0.263899482614658,201,pan-cancer mRNA,CTRPv2,FK866,AAC,0.0428225329757014,0.264002891866396,298,pan-cancer mRNA,CTRPv2,CCT036477,AAC,0.0378479938502322,0.264461643051128,207,pan-cancer mRNA,CTRPv2,BRD-M00053801,AAC,0.0539289338357274,0.265761433890694,176,pan-cancer mRNA,GDSC1000,PLX4720,AAC,0.0344602473831336,0.265785043039583,569,pan-cancer mRNA,GDSC1000,THZ-2-49,AAC,0.0330103266744946,0.269762178967504,688,pan-cancer mRNA,CTRPv2,SID 26681509,AAC,0.042473798227962,0.271506589720115,635,pan-cancer mRNA,GDSC1000,lapatinib,AAC,-0.0526332412550811,0.272166834936404,415,pan-cancer mRNA,CTRPv2,EX-527,AAC,-0.0433891470628615,0.272636630346826,293,pan-cancer mRNA,GDSC1000,XMD11-85h,AAC,-0.0531179674593708,0.273267170207898,742,pan-cancer mRNA,CTRPv2,BRD-K71781559,AAC,0.0427006812061411,0.27612497613541,158,pan-cancer mRNA,CTRPv2,QS11,AAC,-0.0796691282654391,0.276325024723111,586,pan-cancer mRNA,CTRPv2,BRD-K63431240,AAC,0.0392525674921605,0.276758630505215,153,pan-cancer mRNA,GDSC1000,Talazoparib,AAC,-0.0363639692511234,0.283494238470704,671,pan-cancer mRNA,CTRPv2,oligomycin a,AAC,0.0386922398024103,0.284777617547348,515,pan-cancer mRNA,CTRPv2,brivanib,AAC,0.0384656916717989,0.286691714046516,187,pan-cancer mRNA,CTRPv2,BRD-K30748066,AAC,0.131722229619559,0.287563110065853,129,pan-cancer mRNA,CTRPv2,Panobinostat,AAC,0.0359955399483544,0.287850628478041,529,pan-cancer mRNA,CTRPv2,BRD-K19103580,AAC,0.0400502165266787,0.290243838938299,117,pan-cancer mRNA,GDSC1000,CP724714,AAC,-0.0357571229635311,0.293453877829047,246,pan-cancer mRNA,CTRPv2,BRD-K27986637,AAC,-0.0770893113750241,0.295467715188422,124,pan-cancer mRNA,CTRPv2,navitoclax:MST-312 (1:1 mol/mol),AAC,0.0384003220610715,0.295554994562466,477,pan-cancer mRNA,CTRPv2,NSC95397,AAC,0.0351741353501476,0.29569600088014,504,pan-cancer mRNA,FIMM,AZD-2281,AAC,-0.195812708925093,0.296290222727973,51,pan-cancer mRNA,CTRPv2,selumetinib:BRD-A02303741 (4:1 mol/mol),AAC,0.0367711854766988,0.29901882395132,618,pan-cancer mRNA,CTRPv2,SKI-II,AAC,0.0384659350854227,0.301486987138635,644,pan-cancer mRNA,GDSC1000,phenformin,AAC,-0.0323618692413299,0.302220745440188,556,pan-cancer mRNA,CTRPv2,BRD1812,AAC,0.0367401978282493,0.302829204795602,177,pan-cancer mRNA,CTRPv2,YM-155,AAC,-0.039514627808805,0.302860242274269,752,pan-cancer mRNA,GDSC1000,GSK429286A,AAC,-0.0339616123889664,0.303443403304393,337,pan-cancer mRNA,GDSC1000,NSC-87877,AAC,-0.036906252288443,0.303950809306347,497,pan-cancer mRNA,CTRPv2,QW-BI-011,AAC,0.0709955458619933,0.304166563631195,588,pan-cancer mRNA,GDSC1000,GDC-0449,AAC,-0.0372913701732844,0.305440469133063,311,pan-cancer mRNA,CTRPv2,BRD-K24690302,AAC,0.0379245482949965,0.307797503564145,119,pan-cancer mRNA,CTRPv2,valdecoxib,AAC,0.0364933933265303,0.312508354339434,715,pan-cancer mRNA,CTRPv2,BRD-A02303741:carboplatin (1:1 mol/mol),AAC,-0.0386218164430583,0.312532770190251,95,pan-cancer mRNA,GDSC1000,FH535,AAC,0.0349723441863255,0.31379903263255,296,pan-cancer mRNA,CTRPv2,MK-0752,AAC,0.0390716713831227,0.314515220576073,447,pan-cancer mRNA,CTRPv2,KU-55933,AAC,0.0371465888610789,0.315875539430256,409,pan-cancer mRNA,CTRPv2,Compound 7d-cis,AAC,0.0373525348690238,0.316217440592583,244,pan-cancer mRNA,CTRPv2,ATRA,AAC,0.0354570536676878,0.316518697619477,42,pan-cancer mRNA,GDSC1000,ruxolitinib,AAC,-0.0338620062065543,0.316595592203194,602,pan-cancer mRNA,gCSI,Rapamycin,AAC,-0.0544938085343871,0.316861520517962,591,pan-cancer mRNA,CTRPv2,navitoclax:PLX-4032 (1:1 mol/mol),AAC,0.0357108799642238,0.317030366961086,480,pan-cancer mRNA,CTRPv2,importazole,AAC,0.0390561371105889,0.317617145063311,362,pan-cancer mRNA,CTRPv2,KU-60019,AAC,0.0351820110118993,0.319877126388283,410,pan-cancer mRNA,CTRPv2,BRD-A05715709,AAC,0.0562527740710129,0.322367095373837,97,pan-cancer mRNA,GDSC1000,XL-184,AAC,-0.0338581655431623,0.325387822946308,740,pan-cancer mRNA,CTRPv2,BRD-A71883111,AAC,0.036826344010282,0.325666967981167,98,pan-cancer mRNA,CTRPv2,LRRK2-IN-1,AAC,0.0366213795331235,0.327074363083962,428,pan-cancer mRNA,GDSC1000,PF-562271,AAC,0.0335580016935157,0.327251509659532,550,pan-cancer mRNA,CTRPv2,MLN2238,AAC,0.0338040328621618,0.329704986090438,462,pan-cancer mRNA,CTRPv2,GSK1059615,AAC,0.0451060482504023,0.329735100373423,326,pan-cancer mRNA,CTRPv2,canertinib,AAC,0.0353979131397219,0.335334897105707,196,pan-cancer mRNA,GDSC1000,AKT inhibitor VIII,AAC,-0.0335200219058509,0.335508263852418,26,pan-cancer mRNA,FIMM,Dasatinib,AAC,-0.176400961711825,0.336733708470248,262,pan-cancer mRNA,GDSC1000,tivozanib,AAC,-0.033271038927172,0.337632097338298,693,pan-cancer mRNA,GDSC1000,LY317615,AAC,-0.0329516375249366,0.338724808253537,431,pan-cancer mRNA,CTRPv2,selumetinib:MK-2206 (8:1 mol/mol),AAC,0.0341952716803132,0.339423079694429,622,pan-cancer mRNA,CTRPv2,MGCD-265,AAC,0.033285974096079,0.340320599257876,441,pan-cancer mRNA,CTRPv2,BRD-K16147474,AAC,0.0382285719101844,0.340759596857784,115,pan-cancer mRNA,GDSC1000,XMD13-2,AAC,-0.030070377314786,0.341569020581137,743,pan-cancer mRNA,CTRPv2,FGIN-1-27,AAC,0.0704080284840941,0.343579609076278,295,pan-cancer mRNA,GDSC1000,FR-180204,AAC,0.0323697458129585,0.34697968246504,304,pan-cancer mRNA,CTRPv2,BRD-K33514849,AAC,0.124124177394433,0.348074928921694,131,pan-cancer mRNA,GDSC1000,Bicalutamide,AAC,-0.0317745553480546,0.349569867503607,77,pan-cancer mRNA,gCSI,Bortezomib,AAC,0.0549367740042735,0.352455354811643,92,pan-cancer mRNA,gCSI,MS-275,AAC,-0.0488204106172466,0.353435770703884,468,pan-cancer mRNA,GDSC1000,VX-680,AAC,0.0489992800237402,0.353436135484667,730,pan-cancer mRNA,GDSC1000,dabrafenib,AAC,0.0283000240045819,0.354418425862175,259,pan-cancer mRNA,GDSC1000,KIN001-055,AAC,-0.0316340340257585,0.354953872722776,397,pan-cancer mRNA,CTRPv2,erlotinib:PLX-4032 (2:1 mol/mol),AAC,0.0351088542857816,0.357359095822071,288,pan-cancer mRNA,CTRPv2,BRD-K90370028,AAC,-0.0511070394488935,0.358680940180378,168,pan-cancer mRNA,FIMM,ABT-263,AAC,0.152312307046228,0.358863731596582,16,pan-cancer mRNA,CTRPv2,navitoclax:sorafenib (1:1 mol/mol),AAC,0.0325608266829192,0.359850838349886,481,pan-cancer mRNA,GDSC1000,CX-5461,AAC,-0.028766340779184,0.370233003707679,253,pan-cancer mRNA,GDSC1000,Epothilone B,AAC,0.0313853913470656,0.372166323312184,283,pan-cancer mRNA,CTRPv2,BIRB 0796,AAC,0.0338464080543118,0.374484733202298,79,pan-cancer mRNA,GDSC1000,AS601245,AAC,-0.0312607221688269,0.374880621230256,36,pan-cancer mRNA,GDSC1000,Pazopanib,AAC,-0.0306544192300952,0.376253084767514,533,pan-cancer mRNA,GDSC1000,WZ3105,AAC,-0.0265805032512391,0.377234990679855,736,pan-cancer mRNA,gCSI,lapatinib,AAC,0.0473536016436839,0.377541711752199,415,pan-cancer mRNA,CTRPv2,SGX-523,AAC,0.0332448383306482,0.377808665360548,633,pan-cancer mRNA,CTRPv2,BRD-K84807411,AAC,-0.0648654352571073,0.378377443676856,164,pan-cancer mRNA,FIMM,Tipifarnib,AAC,-0.12819349505091,0.380083137906261,691,pan-cancer mRNA,CTRPv2,selumetinib:PLX-4032 (8:1 mol/mol),AAC,0.031307044764366,0.380883402007906,625,pan-cancer mRNA,GDSC1000,GSK269962A,AAC,-0.0284822951163043,0.384625604059767,335,pan-cancer mRNA,CTRPv2,fulvestrant,AAC,0.0684000541006561,0.386305130903671,308,pan-cancer mRNA,CTRPv2,triptolide,AAC,0.0308717273023301,0.388251578406912,706,pan-cancer mRNA,GDSC1000,GW843682X,AAC,0.0443750594842109,0.390746818894312,345,pan-cancer mRNA,GDSC1000,TPCA-1,AAC,-0.0248930660658253,0.39206107500645,699,pan-cancer mRNA,GDSC1000,NG-25,AAC,-0.0256309347311182,0.392156467571986,489,pan-cancer mRNA,GDSC1000,NVP-BEZ235,AAC,-0.0298252537454354,0.3930887135592,511,pan-cancer mRNA,CTRPv2,PX-12,AAC,0.0246712679370179,0.393815920750357,577,pan-cancer mRNA,CTRPv2,WAY-362450,AAC,-0.0322666529764162,0.394499840167642,732,pan-cancer mRNA,CTRPv2,BRD-K20514654,AAC,0.0436181810666663,0.394990520284995,118,pan-cancer mRNA,GDSC1000,KIN001-135,AAC,-0.046640615608348,0.395304109293193,399,pan-cancer mRNA,CTRPv2,DBeQ,AAC,0.0317052747520173,0.39582524368214,263,pan-cancer mRNA,GDSC1000,TW 37,AAC,0.0282635598095695,0.396153905028136,708,pan-cancer mRNA,CTRPv2,lenvatinib,AAC,-0.0313125055146596,0.398823660650616,420,pan-cancer mRNA,FIMM,Bortezomib,AAC,-0.140900950874515,0.39889395427396,92,pan-cancer mRNA,CTRPv2,JW-74,AAC,-0.0387603961836947,0.400446486866165,393,pan-cancer mRNA,CTRPv2,STF-31,AAC,0.0300727290486679,0.401248168365246,660,pan-cancer mRNA,CTRPv2,nelarabine,AAC,0.032830186262608,0.402397722206047,485,pan-cancer mRNA,GDSC1000,ZG-10,AAC,-0.0377772063611779,0.403612224827192,756,pan-cancer mRNA,GDSC1000,Camptothecin,AAC,0.0284673097257838,0.407227597329725,195,pan-cancer mRNA,CTRPv2,SNS-032,AAC,0.0299473095250065,0.409024301199724,648,pan-cancer mRNA,GDSC1000,SB52334,AAC,-0.0275678608514332,0.410009951991388,614,pan-cancer mRNA,CTRPv2,trifluoperazine,AAC,0.0324099177429643,0.410178025857664,705,pan-cancer mRNA,CTRPv2,ouabain,AAC,-0.0291044794511853,0.410984411207767,522,pan-cancer mRNA,CTRPv2,Vandetanib,AAC,-0.0302093282114245,0.411682974111879,717,pan-cancer mRNA,FIMM,17-AAG,AAC,-0.163987543497112,0.411727117856146,3,pan-cancer mRNA,CTRPv2,BRD6340,AAC,0.0289066184694279,0.411796825214132,180,pan-cancer mRNA,CTRPv2,WZ8040,AAC,0.0321799041626449,0.41281976275358,738,pan-cancer mRNA,CTRPv2,istradefylline,AAC,-0.0457536179363305,0.413399711330571,375,pan-cancer mRNA,CTRPv2,fingolimod,AAC,-0.0294873125771593,0.413451665490011,297,pan-cancer mRNA,CTRPv2,NPC-26,AAC,0.0321595961536016,0.413603556762885,493,pan-cancer mRNA,FIMM,Crizotinib,AAC,-0.163220128147671,0.414118100679009,248,pan-cancer mRNA,GDSC1000,I-BET-762,AAC,-0.0226146237933577,0.414129361665628,353,pan-cancer mRNA,FIMM,AZD0530,AAC,-0.149914816064401,0.414666016284295,53,pan-cancer mRNA,FIMM,Bicalutamide,AAC,-0.155041208583238,0.41628689605517,77,pan-cancer mRNA,gCSI,Erlotinib,AAC,0.0453295376353509,0.417038062762926,287,pan-cancer mRNA,CTRPv2,JW-55,AAC,-0.0642970449077424,0.419936202628867,390,pan-cancer mRNA,GDSC1000,FMK,AAC,-0.0302309861977242,0.42163328599386,300,pan-cancer mRNA,CCLE,AZD0530,AAC,-0.0375657588167661,0.421781483948503,53,pan-cancer mRNA,CTRPv2,TG-101348,AAC,0.0271956619018683,0.424447858020332,683,pan-cancer mRNA,GDSC1000,LAQ824,AAC,-0.0273356235723259,0.426250806812542,416,pan-cancer mRNA,CTRPv2,ETP-46464,AAC,0.0343105902425809,0.427355610960754,291,pan-cancer mRNA,CTRPv2,Parthenolide,AAC,-0.0307000953072603,0.428314588361717,531,pan-cancer mRNA,CTRPv2,tubastatin A,AAC,0.0397269175631201,0.43090045475983,707,pan-cancer mRNA,CTRPv2,BRD-K85133207,AAC,0.0295445446149823,0.432451747227457,165,pan-cancer mRNA,CTRPv2,BRD-K01737880,AAC,0.0997955637483871,0.433206869837352,101,pan-cancer mRNA,CTRPv2,NSC 74859,AAC,0.0303624290452784,0.439757877491375,495,pan-cancer mRNA,CTRPv2,LY-2157299,AAC,0.0581663178938672,0.440349533348584,429,pan-cancer mRNA,CTRPv2,etomoxir,AAC,0.0297093260669926,0.441092721623573,289,pan-cancer mRNA,GDSC1000,Sunitinib,AAC,0.0393426924515006,0.442517785827954,663,pan-cancer mRNA,FIMM,ATRA,AAC,-0.130960579081212,0.444219999229843,42,pan-cancer mRNA,FIMM,Bryostatin 1,AAC,0.121668600530395,0.444389763750841,188,pan-cancer mRNA,CTRPv2,TG-100-115,AAC,0.0285191332603233,0.446391773842885,682,pan-cancer mRNA,GDSC1000,Docetaxel,AAC,0.0242119848538421,0.44642100335932,271,pan-cancer mRNA,CTRPv2,necrostatin-1,AAC,0.0283362689407044,0.450937692896693,482,pan-cancer mRNA,CTRPv2,AZD-7545,AAC,0.027940501523093,0.453225835701011,52,pan-cancer mRNA,CTRPv2,Teniposide,AAC,0.0302714132853867,0.45362824646255,681,pan-cancer mRNA,CTRPv2,CAL-101,AAC,-0.0274011084580984,0.458581513236251,194,pan-cancer mRNA,GDSC1000,CUDC-101,AAC,-0.0231669963422348,0.46059004584966,251,pan-cancer mRNA,CTRPv2,nintedanib,AAC,0.0277982704936807,0.462311123508194,492,pan-cancer mRNA,CTRPv2,pitstop2,AAC,0.0341865721591913,0.463904234104192,564,pan-cancer mRNA,CTRPv2,BMS-195614,AAC,0.0283600492435102,0.463908097681483,85,pan-cancer mRNA,CTRPv2,piperlongumine,AAC,0.0238615533704595,0.464335507419841,562,pan-cancer mRNA,CTRPv2,Obatoclax Mesylate,AAC,0.0250876629622637,0.464471769079085,514,pan-cancer mRNA,GDSC1000,OSI-930,AAC,-0.0254116713617587,0.464498465384102,520,pan-cancer mRNA,CTRPv2,AT13387,AAC,0.0343359419392994,0.464913081535152,40,pan-cancer mRNA,GDSC1000,IPA-3,AAC,-0.0242969777726303,0.465977545959353,365,pan-cancer mRNA,FIMM,Gefitinib,AAC,0.131525266669667,0.468955360679003,314,pan-cancer mRNA,CTRPv2,BRD-K86535717,AAC,-0.0538286174291348,0.469553450696807,166,pan-cancer mRNA,CTRPv2,KPT185,AAC,0.0279985821575974,0.469955395242748,406,pan-cancer mRNA,CTRPv2,tretinoin:navitoclax (4:1 mol/mol),AAC,0.0255449639915271,0.470312691234748,701,pan-cancer mRNA,GDSC1000,NPK76-II-72-1,AAC,0.0214029778683483,0.470377310540471,494,pan-cancer mRNA,CTRPv2,MK-2206,AAC,0.0262543205688015,0.472895989612931,448,pan-cancer mRNA,CTRPv2,RO4929097,AAC,-0.0385961124024085,0.474363152060231,599,pan-cancer mRNA,GDSC1000,XMD15-27,AAC,-0.0247286163217103,0.475045536116513,745,pan-cancer mRNA,CCLE,TAE684,AAC,-0.0317038112093136,0.476702892580935,669,pan-cancer mRNA,CTRPv2,BRD8958,AAC,0.0280033756758881,0.479144478962054,182,pan-cancer mRNA,CCLE,Erlotinib,AAC,0.0318746953408035,0.479457028312352,287,pan-cancer mRNA,CTRPv2,Platin,AAC,-0.0264129899638664,0.486381587226216,566,pan-cancer mRNA,CTRPv2,AC55649,AAC,0.0269050740686771,0.487177058907128,20,pan-cancer mRNA,FIMM,Axitinib,AAC,-0.124129427580768,0.488720346284735,47,pan-cancer mRNA,GDSC1000,SL 0101-1,AAC,0.0251717588043468,0.48961162046514,645,pan-cancer mRNA,CTRPv2,BRD-A02303741,AAC,0.0270397250188255,0.49353854081094,94,pan-cancer mRNA,FIMM,Imatinib,AAC,-0.13679610388328,0.493564572397473,361,pan-cancer mRNA,GDSC1000,masitinib,AAC,-0.0223251562145364,0.49405787191245,434,pan-cancer mRNA,GDSC1000,Methotrexate,AAC,0.0204052487071295,0.495107947759641,438,pan-cancer mRNA,CTRPv2,lovastatin,AAC,-0.0254745740295834,0.49540339586891,427,pan-cancer mRNA,GDSC1000,piperlongumine,AAC,-0.022654269244747,0.495585990819907,562,pan-cancer mRNA,FIMM,Bexarotene,AAC,-0.118129422639117,0.497711710656011,72,pan-cancer mRNA,GDSC1000,SB 216763,AAC,0.0262315044778115,0.497760662578283,607,pan-cancer mRNA,CTRPv2,CIL55A,AAC,0.0344581552300975,0.498020979356639,233,pan-cancer mRNA,FIMM,Vorinostat,AAC,0.119438523363022,0.499544097114169,725,pan-cancer mRNA,FIMM,Cytarabine,AAC,-0.118697744069343,0.499663986980066,257,pan-cancer mRNA,CTRPv2,semagacestat,AAC,-0.0252701682775782,0.500450555345864,629,pan-cancer mRNA,GDSC1000,SN-38,AAC,-0.0226606122613628,0.500893889521891,647,pan-cancer mRNA,CTRPv2,Cerulenin,AAC,-0.0224165165258614,0.502640474306097,213,pan-cancer mRNA,CTRPv2,AZD8055,AAC,-0.024026943191604,0.502922726615034,59,pan-cancer mRNA,CTRPv2,BRD-K34485477,AAC,0.0514226898883597,0.503113167804776,134,pan-cancer mRNA,CTRPv2,Sunitinib,AAC,0.0233609216877019,0.50523706763283,663,pan-cancer mRNA,CTRPv2,WP1130,AAC,0.0238773960720462,0.505962544555321,734,pan-cancer mRNA,CTRPv2,FSC231,AAC,0.0480498057084679,0.506977872608699,305,pan-cancer mRNA,GDSC1000,XAV-939,AAC,-0.0231120700771021,0.506990477392988,739,pan-cancer mRNA,GDSC1000,MS-275,AAC,-0.0340500222073981,0.510835829761229,468,pan-cancer mRNA,GDSC1000,Erlotinib,AAC,-0.0317267311923088,0.513876249130361,287,pan-cancer mRNA,CTRPv2,purmorphamine,AAC,0.0249703657705464,0.514136372108279,575,pan-cancer mRNA,CTRPv2,BIBW2992,AAC,0.0240822891014923,0.514761290655732,76,pan-cancer mRNA,GDSC1000,CCT007093,AAC,-0.0226208061832687,0.515186716533833,205,pan-cancer mRNA,CTRPv2,PF-750,AAC,0.0249993510520121,0.519644369687711,552,pan-cancer mRNA,CTRPv2,BRD-K09587429,AAC,-0.0262113003966352,0.519849726487451,109,pan-cancer mRNA,CTRPv2,GDC-0941,AAC,0.023626869577758,0.520900340901506,313,pan-cancer mRNA,GDSC1000,MPS-1-IN-1,AAC,0.0206721175411814,0.521085639669245,467,pan-cancer mRNA,GDSC1000,Gefitinib,AAC,0.0213107469651098,0.523108454817385,314,pan-cancer mRNA,GDSC1000,Ispinesib Mesylate,AAC,0.0204836373382904,0.524667623529962,374,pan-cancer mRNA,CTRPv2,BRD-K27224038,AAC,-0.0470350433341484,0.525095473617536,123,pan-cancer mRNA,CTRPv2,vorapaxar,AAC,0.0242620125255667,0.525287499569269,724,pan-cancer mRNA,CTRPv2,BRD-K13185470,AAC,-0.0447374558025057,0.525668678064472,111,pan-cancer mRNA,GDSC1000,CI-1040,AAC,0.0210814242503325,0.526708066325092,226,pan-cancer mRNA,CTRPv2,necrosulfonamide,AAC,-0.024515132336772,0.530022423034463,484,pan-cancer mRNA,CTRPv2,AZD7762,AAC,0.0208856393372858,0.530057050369015,58,pan-cancer mRNA,GDSC1000,KIN001-266,AAC,-0.0216874068088511,0.530069272511125,403,pan-cancer mRNA,GDSC1000,temsirolimus,AAC,-0.0215445381398456,0.530606390378551,680,pan-cancer mRNA,gCSI,GDC-0941,AAC,-0.0370331011948246,0.533329769304908,313,pan-cancer mRNA,GDSC1000,ATRA,AAC,0.0211923320638425,0.539367920078676,42,pan-cancer mRNA,CTRPv2,Nilotinib,AAC,0.0229331664736692,0.539464291363106,491,pan-cancer mRNA,CTRPv2,BRD-K79669418,AAC,-0.0326106215533574,0.540663073111911,162,pan-cancer mRNA,CTRPv2,azacitidine,AAC,-0.0233555831318773,0.540711272759,50,pan-cancer mRNA,GDSC1000,RO-3306,AAC,0.0213223044647604,0.543840679944827,598,pan-cancer mRNA,gCSI,thapsigargin,AAC,0.03389171732182,0.544843864477417,686,pan-cancer mRNA,CTRPv2,Bleomycin,AAC,0.022982145269979,0.546394513634263,84,pan-cancer mRNA,GDSC1000,Tamoxifen,AAC,-0.0205436344505972,0.550085645129962,673,pan-cancer mRNA,CTRPv2,BRD-K58730230,AAC,0.0444108128233775,0.551427337182474,151,pan-cancer mRNA,CTRPv2,BRD-K17060750,AAC,-0.022219193769162,0.559652960236526,116,pan-cancer mRNA,CTRPv2,tigecycline,AAC,-0.0284946999303121,0.562197001194375,689,pan-cancer mRNA,GDSC1000,Pyrimethamine,AAC,0.0303094400945729,0.565274148270446,580,pan-cancer mRNA,GDSC1000,Cisplatin,AAC,0.0198864645156947,0.56740561430921,237,pan-cancer mRNA,GDSC1000,PF-4708671,AAC,-0.0199408741946232,0.567793650616678,547,pan-cancer mRNA,GDSC1000,VX-702,AAC,-0.0204542039095127,0.568009275211899,731,pan-cancer mRNA,GDSC1000,Cyclopamine,AAC,0.0301207214524916,0.571388447305373,255,pan-cancer mRNA,GDSC1000,XMD14-99,AAC,-0.0188553845635497,0.572297451595256,744,pan-cancer mRNA,UHNBreast,AZD6244,AAC,0.172680290811864,0.572659067267126,56,pan-cancer mRNA,GDSC1000,Axitinib,AAC,0.0202456739128529,0.57807619412916,47,pan-cancer mRNA,GDSC1000,TGX221,AAC,0.0263765075676581,0.579665176707845,684,pan-cancer mRNA,GDSC1000,tubastatin A,AAC,0.017226587171548,0.579852487018526,707,pan-cancer mRNA,GDSC1000,AUY922,AAC,-0.0195175194091809,0.580173503805381,44,pan-cancer mRNA,GDSC1000,MLN4924,AAC,0.0222331259140796,0.581262268582699,464,pan-cancer mRNA,CTRPv2,PL-DI,AAC,-0.0174771486958264,0.583296446623609,565,pan-cancer mRNA,FIMM,AZD6244,AAC,0.108649796142962,0.584204667269259,56,pan-cancer mRNA,CTRPv2,Bortezomib,AAC,0.0192139670888041,0.585850989991259,92,pan-cancer mRNA,GDSC1000,embelin,AAC,0.0193254133173295,0.588503111271412,280,pan-cancer mRNA,CTRPv2,SR8278,AAC,-0.0726493765346433,0.589511144919881,656,pan-cancer mRNA,GDSC1000,XMD8-92,AAC,-0.025565400711074,0.590018819753433,747,pan-cancer mRNA,CTRPv2,BRD-K16130065,AAC,0.0398565865402972,0.591601628746438,114,pan-cancer mRNA,GDSC1000,GW-2580,AAC,-0.0188471976805564,0.592092739715843,343,pan-cancer mRNA,CCLE,Vandetanib,AAC,-0.0247023157128204,0.593952228120904,717,pan-cancer mRNA,CTRPv2,CIL55,AAC,0.0325984320856144,0.594244545471224,232,pan-cancer mRNA,CTRPv2,JNJ-26854165,AAC,0.0182584975995118,0.59591970209109,379,pan-cancer mRNA,CTRPv2,TGX221,AAC,-0.0198773343899635,0.59779355057934,684,pan-cancer mRNA,CTRPv2,R428,AAC,0.0229546729067225,0.59804410909347,589,pan-cancer mRNA,GDSC1000,TL-2-105,AAC,-0.0172377274098041,0.598669660911618,696,pan-cancer mRNA,GDSC1000,YM-155,AAC,-0.0175554618248194,0.602555727059586,752,pan-cancer mRNA,FIMM,Sunitinib,AAC,-0.0988250927071107,0.607574449001581,663,pan-cancer mRNA,FIMM,Pazopanib,AAC,-0.104024279405493,0.610547248343132,533,pan-cancer mRNA,CTRPv2,procarbazine,AAC,-0.0203349495428689,0.611424033309668,573,pan-cancer mRNA,CTRPv2,Fumonisin B1,AAC,-0.0190268898489244,0.611815760806578,309,pan-cancer mRNA,CTRPv2,Imatinib,AAC,0.0185902891478026,0.612677303470198,361,pan-cancer mRNA,CTRPv2,sirolimus:bortezomib (250:1 mol/mol),AAC,0.0173278571463761,0.612868450543611,640,pan-cancer mRNA,GDSC1000,PD-0332991,AAC,-0.0177546339358202,0.613264176341988,536,pan-cancer mRNA,CTRPv2,MI-2,AAC,0.0270429204195283,0.614518552046716,443,pan-cancer mRNA,CTRPv2,UNC0321,AAC,0.0188583809461483,0.615364203447094,710,pan-cancer mRNA,GDSC1000,BIRB 0796,AAC,-0.0177195849128885,0.617384746108346,79,pan-cancer mRNA,GDSC1000,Roscovitine,AAC,0.0263758586828032,0.617979242643814,600,pan-cancer mRNA,GDSC1000,(5Z)-7-Oxozeaenol,AAC,0.0154936612012891,0.619717512244068,1,pan-cancer mRNA,CTRPv2,BRD-K42260513,AAC,0.0280838455568162,0.620380350791167,139,pan-cancer mRNA,CTRPv2,RG-108,AAC,0.0180900941015637,0.621598946295565,595,pan-cancer mRNA,CTRPv2,BRD-K75293299,AAC,0.0359530468156754,0.625014736943407,160,pan-cancer mRNA,CTRPv2,SR1001,AAC,0.0186485726083119,0.628671705414345,655,pan-cancer mRNA,GDSC1000,YM201636,AAC,-0.0152472318012036,0.629902470406594,753,pan-cancer mRNA,GDSC1000,Tipifarnib,AAC,-0.0171239928038417,0.632893542904859,691,pan-cancer mRNA,gCSI,Irinotecan,AAC,0.0251048786147689,0.633599860986445,367,pan-cancer mRNA,GDSC1000,AR-42,AAC,0.0145417016222735,0.635752628436604,34,pan-cancer mRNA,CTRPv2,cabozantinib,AAC,-0.017567356470098,0.635993779369101,193,pan-cancer mRNA,CTRPv2,BRD-K09344309,AAC,0.037931307763564,0.636183646835321,108,pan-cancer mRNA,FIMM,Panobinostat,AAC,-0.0604303507941117,0.643527715788919,529,pan-cancer mRNA,CTRPv2,ML320,AAC,0.0167571828827307,0.643940422968002,460,pan-cancer mRNA,GDSC1000,PD173074,AAC,-0.0163950672247137,0.64620612467672,537,pan-cancer mRNA,CTRPv2,tipifarnib,AAC,0.0145123323756081,0.646644957605124,690,pan-cancer mRNA,GDSC1000,SGC0946,AAC,-0.0164087405175391,0.6469405729087,632,pan-cancer mRNA,CTRPv2,BRD-K41334119,AAC,-0.0336227467013276,0.650711446210566,137,pan-cancer mRNA,GDSC1000,UNC1215,AAC,0.0157309449865763,0.652487756144185,713,pan-cancer mRNA,CTRPv2,VER-155008,AAC,-0.0164642489832585,0.652606927984772,719,pan-cancer mRNA,FIMM,Nilotinib,AAC,-0.0866196466203239,0.656308706876422,491,pan-cancer mRNA,CTRPv2,Axitinib,AAC,0.0153179716507385,0.657077604043163,47,pan-cancer mRNA,GDSC1000,MP470,AAC,-0.0152661503243872,0.658248896155873,466,pan-cancer mRNA,CTRPv2,compound 1B,AAC,-0.0172072301694311,0.658607642474487,242,pan-cancer mRNA,GDSC1000,Bryostatin 1,AAC,-0.0155770552570355,0.660359466754138,188,pan-cancer mRNA,GDSC1000,Midostaurin,AAC,-0.0153188775401204,0.661910722458313,444,pan-cancer mRNA,GDSC1000,PD-0325901,AAC,0.0143640298508591,0.662874430959012,535,pan-cancer mRNA,CCLE,RAF265,AAC,0.021184166922838,0.664273569236054,590,pan-cancer mRNA,CTRPv2,KU-0063794,AAC,-0.0156277358826033,0.666184196555478,408,pan-cancer mRNA,GDSC1000,CEP-701,AAC,0.0143923427220951,0.666635183222279,211,pan-cancer mRNA,CTRPv2,PD 153035,AAC,-0.0182003495734347,0.6674789107484,534,pan-cancer mRNA,CTRPv2,VX-680,AAC,0.049032492071454,0.667504726187118,730,pan-cancer mRNA,GDSC1000,UNC0638,AAC,0.0128965188889912,0.667889703414162,711,pan-cancer mRNA,CCLE,Sorafenib,AAC,-0.0198533952726244,0.668193339326566,651,pan-cancer mRNA,CTRPv2,MG-132,AAC,-0.0259060529602916,0.669231802010433,440,pan-cancer mRNA,CTRPv2,UNC0638:navitoclax (1:1 mol/mol),AAC,0.0156561858307657,0.67223001604959,712,pan-cancer mRNA,GDSC1000,ZM-447439,AAC,0.0153732391253542,0.677134144023416,758,pan-cancer mRNA,GDSC1000,AP-24534,AAC,-0.0139036703822498,0.680655952370792,32,pan-cancer mRNA,CTRPv2,WZ4002,AAC,0.0182173585710478,0.680917658734511,737,pan-cancer mRNA,CTRPv2,prima-1,AAC,0.0129647991032427,0.683390880362525,570,pan-cancer mRNA,CTRPv2,C6-ceramide,AAC,0.0150900563156932,0.688733783095361,192,pan-cancer mRNA,FIMM,Roscovitine,AAC,-0.0757912858576709,0.689124039944517,600,pan-cancer mRNA,GDSC1000,lenalidomide,AAC,-0.0145704473457385,0.689429599292779,419,pan-cancer mRNA,GDSC1000,CCT018159,AAC,0.01355844999711,0.694555818770983,206,pan-cancer mRNA,GDSC1000,Zibotentan,AAC,-0.0132226380278761,0.696046703398397,757,pan-cancer mRNA,FIMM,AP-24534,AAC,-0.0748979154048126,0.696072559441028,32,pan-cancer mRNA,CTRPv2,BRD-K04800985,AAC,0.0149291910778287,0.696163121900019,106,pan-cancer mRNA,FIMM,CEP-701,AAC,-0.0537704172320593,0.700334992909554,211,pan-cancer mRNA,GDSC1000,EX-527,AAC,-0.0134656968108505,0.700726012937302,293,pan-cancer mRNA,FIMM,PD-0332991,AAC,-0.0711108288955239,0.702692085596143,536,pan-cancer mRNA,CTRPv2,navitoclax:piperlongumine (1:1 mol/mol),AAC,0.0138110022978094,0.704051553356786,478,pan-cancer mRNA,CTRPv2,neopeltolide,AAC,0.0271898862935147,0.704751675392173,487,pan-cancer mRNA,GDSC1000,STF-62247,AAC,0.0124728242477487,0.706765694468483,661,pan-cancer mRNA,GDSC1000,Y-39983,AAC,-0.0121930774421988,0.706973289192582,749,pan-cancer mRNA,GDSC1000,KIN001-244,AAC,-0.0118145347640851,0.708142050296215,401,pan-cancer mRNA,CTRPv2,myricetin,AAC,-0.0143978431737303,0.709512387609168,470,pan-cancer mRNA,CTRPv2,BRD-K34222889,AAC,0.0117759898918551,0.710063210046965,133,pan-cancer mRNA,gCSI,Crizotinib,AAC,0.0208251584193008,0.711085723773521,248,pan-cancer mRNA,CTRPv2,CIL41,AAC,-0.0194007360366056,0.711570215773469,231,pan-cancer mRNA,CTRPv2,Rapamycin,AAC,-0.0127614564629853,0.712724592226676,591,pan-cancer mRNA,CTRPv2,SB-431542,AAC,0.0140626201702268,0.714246082203797,611,pan-cancer mRNA,GDSC1000,BMS-345541,AAC,-0.0115192370701351,0.715092215688789,87,pan-cancer mRNA,CTRPv2,pifithrin-mu,AAC,-0.0127871471036832,0.717889198672325,560,pan-cancer mRNA,GDSC1000,AZD8055,AAC,-0.012150315571365,0.719238903984386,59,pan-cancer mRNA,CTRPv2,ML258,AAC,0.013530535390407,0.721402386039866,457,pan-cancer mRNA,CTRPv2,ML239,AAC,0.0127272379089371,0.725328443786721,456,pan-cancer mRNA,CTRPv2,erismodegib,AAC,-0.013361533041792,0.727641952657059,285,pan-cancer mRNA,FIMM,S-Trityl-L-cysteine,AAC,0.0706048592613217,0.727810494907173,603,pan-cancer mRNA,CTRPv2,BYL-719,AAC,0.0150623151705478,0.73096488881257,191,pan-cancer mRNA,CTRPv2,HBX-41108,AAC,0.0145577743958215,0.731336563912615,346,pan-cancer mRNA,CTRPv2,BRD-K44224150,AAC,-0.0262045655105179,0.732108431787613,140,pan-cancer mRNA,GDSC1000,foretinib,AAC,0.0110500202415073,0.7358759062716,301,pan-cancer mRNA,CTRPv2,tivozanib,AAC,-0.0125112905764622,0.73602913615898,693,pan-cancer mRNA,CCLE,PHA-665752,AAC,0.0156610647443585,0.736232807143241,554,pan-cancer mRNA,CTRPv2,BRD9647,AAC,-0.0126041629406836,0.738629242639818,183,pan-cancer mRNA,CTRPv2,BRD-K48334597,AAC,0.0226541872567293,0.738641466580111,142,pan-cancer mRNA,GDSC1000,PHA-793887,AAC,0.00961319902576095,0.738697404637217,555,pan-cancer mRNA,CTRPv2,ML312,AAC,-0.024727878143894,0.740026014298115,459,pan-cancer mRNA,FIMM,serdemetan,AAC,-0.0588146253232824,0.74079967647597,630,pan-cancer mRNA,CTRPv2,UNC0638,AAC,-0.0121350165600664,0.741818084546468,711,pan-cancer mRNA,GDSC1000,Bortezomib,AAC,-0.0162576728177148,0.744755162953872,92,pan-cancer mRNA,GDSC1000,JQ-1,AAC,-0.0106241142256529,0.748185079161003,382,pan-cancer mRNA,CTRPv2,momelotinib,AAC,-0.011193780851855,0.749455135519015,465,pan-cancer mRNA,GDSC1000,FTI-277,AAC,-0.0109056928764371,0.750708502132602,307,pan-cancer mRNA,gCSI,Doxorubicin,AAC,0.016148993823422,0.751254608533881,273,pan-cancer mRNA,GDSC1000,JNK Inhibitor VIII,AAC,-0.0110117344454409,0.752707820454059,380,pan-cancer mRNA,CTRPv2,PRIMA-1-Met,AAC,0.016870270454408,0.752909346924191,571,pan-cancer mRNA,CTRPv2,BRD-K51490254,AAC,-0.0117787629773932,0.756914496750088,146,pan-cancer mRNA,gCSI,Vorinostat,AAC,0.0157529650451737,0.757724125951395,725,pan-cancer mRNA,FIMM,RDEA119,AAC,0.0586746344541813,0.759125007221953,592,pan-cancer mRNA,CTRPv2,BRD-K03536150,AAC,0.0115412734688042,0.759361058032151,104,pan-cancer mRNA,CTRPv2,BRD-K27188169,AAC,0.0159662859281797,0.765487610732639,121,pan-cancer mRNA,CTRPv2,CID-5951923,AAC,-0.0114438127539798,0.767208717715099,230,pan-cancer mRNA,CTRPv2,BRD-K13999467,AAC,0.0107474962602711,0.768446627608271,112,pan-cancer mRNA,CTRPv2,ABT-888,AAC,-0.01093230200427,0.768818862595387,18,pan-cancer mRNA,GDSC1000,JW-7-52-1,AAC,-0.0148079637933078,0.775917960359357,392,pan-cancer mRNA,FIMM,BIRB 0796,AAC,-0.0589715007284049,0.776044702881125,79,pan-cancer mRNA,CTRPv2,neratinib,AAC,-0.0101578180568444,0.778149179660238,488,pan-cancer mRNA,CTRPv2,ifosfamide,AAC,-0.015218668481071,0.778705300718411,359,pan-cancer mRNA,GDSC1000,BHG712,AAC,0.00837959109861735,0.780235033025111,73,pan-cancer mRNA,CCLE,AEW541,AAC,-0.0126683998147487,0.781017392261182,21,pan-cancer mRNA,CTRPv2,Sildenafil,AAC,0.0107250193467076,0.782354592340633,637,pan-cancer mRNA,CTRPv2,BRD-K78574327,AAC,0.0204532853412253,0.78276733103914,161,pan-cancer mRNA,GDSC1000,linifanib,AAC,0.00972687561699652,0.782803463692018,424,pan-cancer mRNA,CTRPv2,AT7867,AAC,0.00966802595417949,0.786350127224416,41,pan-cancer mRNA,CTRPv2,OSI-027,AAC,0.00959573524060592,0.787241313051225,518,pan-cancer mRNA,CTRPv2,GSK1120212,AAC,-0.013277152156863,0.787575268007553,329,pan-cancer mRNA,CTRPv2,KH-CB19,AAC,0.0127087019679797,0.78817072488114,394,pan-cancer mRNA,CTRPv2,SJ-172550,AAC,-0.0103901374296216,0.788324945278035,642,pan-cancer mRNA,CTRPv2,quizartinib,AAC,0.010037061216124,0.790712644705227,587,pan-cancer mRNA,CTRPv2,BRD-A86708339,AAC,0.0135089496866285,0.790922775782946,99,pan-cancer mRNA,CTRPv2,PF-4800567 hydrochloride,AAC,-0.0145489703945164,0.791396570768436,548,pan-cancer mRNA,FIMM,lapatinib,AAC,0.0493313182631656,0.791743779042389,415,pan-cancer mRNA,GDSC1000,SB 505124,AAC,-0.00908457158488059,0.793465742242918,608,pan-cancer mRNA,GDSC1000,FK866,AAC,-0.00793989794222549,0.79777513586358,298,pan-cancer mRNA,CTRPv2,palmostatin B,AAC,0.0116770745579523,0.798618962090177,527,pan-cancer mRNA,gCSI,bid1870,AAC,-0.0139011182997008,0.799315967531577,78,pan-cancer mRNA,CTRPv2,ML203,AAC,-0.00969935360759571,0.800108915057874,454,pan-cancer mRNA,CTRPv2,CAY10576,AAC,0.0101498735625261,0.800431170354333,200,pan-cancer mRNA,CTRPv2,BRD-K71935468,AAC,-0.0097995059737833,0.800843125966324,159,pan-cancer mRNA,GDSC1000,GNF-2,AAC,-0.0129922477429895,0.804878978328281,320,pan-cancer mRNA,CTRPv2,NVP-BEZ235,AAC,-0.010520790177099,0.805202374381659,511,pan-cancer mRNA,CTRPv2,sotrastaurin,AAC,0.00987998861825727,0.806664579213841,652,pan-cancer mRNA,CTRPv2,SRT-1720,AAC,0.00915444094708604,0.807180911379888,657,pan-cancer mRNA,CTRPv2,BEC,AAC,-0.0180623345338735,0.807495182345333,68,pan-cancer mRNA,CTRPv2,ML334 diastereomer,AAC,-0.0110369037018697,0.807879177037824,461,pan-cancer mRNA,CTRPv2,temsirolimus,AAC,0.0117460072748168,0.8105800752415,680,pan-cancer mRNA,CTRPv2,pandacostat,AAC,0.00901670396710239,0.811373762736351,528,pan-cancer mRNA,GDSC1000,JNK-9L,AAC,-0.00845779466713363,0.811893926590625,381,pan-cancer mRNA,CTRPv2,MST-312,AAC,0.00842263488453309,0.812243611259502,469,pan-cancer mRNA,GDSC1000,GDC-0941,AAC,0.00795769191965583,0.812985242275308,313,pan-cancer mRNA,CTRPv2,BRD-K02492147,AAC,-0.00964537106898204,0.814978099691797,103,pan-cancer mRNA,CTRPv2,skepinone-L,AAC,-0.0119777422734468,0.816702155609885,643,pan-cancer mRNA,GDSC1000,MG-132,AAC,0.0113757155633347,0.818667870257628,440,pan-cancer mRNA,GDSC1000,Vinorelbine,AAC,-0.00787852573802436,0.824259672849149,722,pan-cancer mRNA,GDSC1000,Obatoclax Mesylate,AAC,0.00769091092776542,0.824619219642404,514,pan-cancer mRNA,GDSC1000,PFI-1,AAC,-0.0074290168110203,0.824789952816534,553,pan-cancer mRNA,GDSC1000,MK-2206,AAC,-0.00813104147289101,0.824959126356734,448,pan-cancer mRNA,CTRPv2,tamatinib,AAC,-0.00833209834142942,0.825178312090059,672,pan-cancer mRNA,CTRPv2,BRD-K96970199,AAC,0.0157798365572012,0.830610529162677,172,pan-cancer mRNA,CTRPv2,ML083,AAC,-0.0080705256733391,0.836939553412612,452,pan-cancer mRNA,GDSC1000,NU-7441,AAC,-0.00723587926549562,0.842491452479189,505,pan-cancer mRNA,CTRPv2,ibrutinib,AAC,-0.00829970689019362,0.844238098793485,356,pan-cancer mRNA,GDSC1000,CAY10603,AAC,-0.00599478117396676,0.844440944983502,202,pan-cancer mRNA,CTRPv2,BRD-K92856060,AAC,0.0069991344044418,0.848122650940143,169,pan-cancer mRNA,CTRPv2,staurosporine,AAC,0.0136574541867182,0.852544677770484,658,pan-cancer mRNA,CTRPv2,IPR-456,AAC,0.0069783145160509,0.855567850065686,366,pan-cancer mRNA,CTRPv2,navitoclax:pluripotin (1:1 mol/mol),AAC,0.00659088722467088,0.85619995239915,479,pan-cancer mRNA,GDSC1000,etoposide,AAC,0.00635576986522644,0.857516066007995,290,pan-cancer mRNA,CTRPv2,isonicotinohydroxamic acid,AAC,-0.0084004710857381,0.859608731283353,370,pan-cancer mRNA,GDSC1000,Bleomycin,AAC,-0.00616781243599735,0.864222251212446,84,pan-cancer mRNA,CTRPv2,BRD-K51831558,AAC,0.0090443908324782,0.865285951494226,147,pan-cancer mRNA,GDSC1000,Rapamycin,AAC,0.00856437816526793,0.865581464604026,591,pan-cancer mRNA,FIMM,AMG-706,AAC,0.0309166138004283,0.868239223893592,31,pan-cancer mRNA,CTRPv2,fluvastatin,AAC,-0.00602458818512953,0.871236078918228,299,pan-cancer mRNA,CTRPv2,VU0155056,AAC,-0.00612891857624928,0.87235141690839,728,pan-cancer mRNA,CTRPv2,Erlotinib,AAC,0.0054719018752806,0.876666701914888,287,pan-cancer mRNA,CTRPv2,AZD1480,AAC,0.00816768365702123,0.879910344206784,54,pan-cancer mRNA,CTRPv2,tandutinib,AAC,0.00539159369739523,0.883317555007249,674,pan-cancer mRNA,CTRPv2,BRD-K30019337,AAC,-0.0104573381563975,0.883362484471768,128,pan-cancer mRNA,CTRPv2,BRD-K99584050,AAC,0.0077431123743781,0.885311914375824,175,pan-cancer mRNA,GDSC1000,KIN001-260,AAC,0.00453814047798952,0.885678570686175,402,pan-cancer mRNA,CCLE,Nutlin-3,AAC,-0.00673406678136639,0.885688479755012,507,pan-cancer mRNA,FIMM,GDC-0449,AAC,0.0277444027468986,0.888371246270953,311,pan-cancer mRNA,CTRPv2,GMX-1778,AAC,-0.00498932149980455,0.8899254250409,319,pan-cancer mRNA,FIMM,lenalidomide,AAC,0.0250720232272429,0.893984310688162,419,pan-cancer mRNA,FIMM,Doxorubicin,AAC,0.0219155293976313,0.894043844438749,273,pan-cancer mRNA,GDSC1000,BAY 61-3606,AAC,-0.00459051883711377,0.894964446112205,66,pan-cancer mRNA,FIMM,Sorafenib,AAC,-0.0250933219988455,0.895876290422834,651,pan-cancer mRNA,CTRPv2,BCL-LZH-4,AAC,-0.00680048974719486,0.899699078807099,67,pan-cancer mRNA,CTRPv2,BRD-K26531177,AAC,-0.00467323482767508,0.900363697384755,120,pan-cancer mRNA,GDSC1000,Parthenolide,AAC,0.00637028330381057,0.904609127328113,531,pan-cancer mRNA,GDSC1000,Elesclomol,AAC,-0.00411932570746307,0.905298971990532,278,pan-cancer mRNA,CTRPv2,MLN2480,AAC,0.00640655183697374,0.905766521790448,463,pan-cancer mRNA,GDSC1000,AMG-706,AAC,-0.00407485284573855,0.90827186957399,31,pan-cancer mRNA,CTRPv2,spautin-1,AAC,-0.00429982769187181,0.910074092990533,653,pan-cancer mRNA,GDSC1000,681640,AAC,-0.004192339294932,0.911901910050276,8,pan-cancer mRNA,CTRPv2,BRD-K96431673,AAC,0.00785951770349942,0.914957737767399,171,pan-cancer mRNA,CTRPv2,BRD-K99006945,AAC,0.00560628594091823,0.915660210256783,174,pan-cancer mRNA,CTRPv2,CIL70,AAC,0.00505655205721317,0.916770833073696,235,pan-cancer mRNA,CTRPv2,IC-87114,AAC,-0.00385690420159719,0.918686975845758,357,pan-cancer mRNA,CTRPv2,Ki8751,AAC,0.00353893509062503,0.922416988696654,396,pan-cancer mRNA,GDSC1000,HG-5-113-01,AAC,-0.00446617657151349,0.92315360041351,348,pan-cancer mRNA,CTRPv2,BRD-K35604418,AAC,0.00342721945000305,0.927413585924497,135,pan-cancer mRNA,FIMM,BIBW2992,AAC,-0.015635083864858,0.92960083699519,76,pan-cancer mRNA,CTRPv2,AZD4547,AAC,-0.00341044794009239,0.9296569578025,55,pan-cancer mRNA,CTRPv2,ML050,AAC,-0.00331109865215735,0.930142558760902,451,pan-cancer mRNA,CTRPv2,PRL-3 Inhibitor I,AAC,0.00336127432145779,0.931126276436889,572,pan-cancer mRNA,GDSC1000,KIN001-270,AAC,-0.00294974190918825,0.931222536359272,404,pan-cancer mRNA,CTRPv2,foretinib,AAC,0.00294931308382471,0.934371937512791,301,pan-cancer mRNA,GDSC1000,BX-912,AAC,-0.00217623720042667,0.942861487953674,190,pan-cancer mRNA,GDSC1000,IOX2,AAC,0.00231174543939652,0.945958468807761,364,pan-cancer mRNA,GDSC1000,JQ12,AAC,-0.00228107921965488,0.94849912294141,388,pan-cancer mRNA,GDSC1000,Bosutinib,AAC,0.00218520455138224,0.948725030022227,93,pan-cancer mRNA,GDSC1000,DMOG,AAC,-0.00205286966162878,0.95029732936002,270,pan-cancer mRNA,GDSC1000,HG-5-88-01,AAC,-0.00289756857445395,0.950479949178836,349,pan-cancer mRNA,GDSC1000,BI-2536,AAC,-0.00318748348984153,0.951361369070604,74,pan-cancer mRNA,CTRPv2,CHIR-99021,AAC,0.00201857336479233,0.952532924650155,223,pan-cancer mRNA,CTRPv2,BRD-K45681478,AAC,0.00215522895806698,0.953009067345309,141,pan-cancer mRNA,GDSC1000,Bexarotene,AAC,-0.00208563909519602,0.953974871923781,72,pan-cancer mRNA,CTRPv2,BRD-K07442505,AAC,0.00194481747235537,0.958851131236284,107,pan-cancer mRNA,CTRPv2,XL765,AAC,-0.00184216770030039,0.961423245895783,741,pan-cancer mRNA,CTRPv2,BRD-K49290616,AAC,0.00360546532516434,0.962095406011057,144,pan-cancer mRNA,CTRPv2,YL54,AAC,0.00175980548605454,0.964580277834975,751,pan-cancer mRNA,GDSC1000,QL-XI-92,AAC,-0.00135403650174373,0.965166827211462,583,pan-cancer mRNA,GDSC1000,QS11,AAC,0.00152773132790004,0.965953110732297,586,pan-cancer mRNA,CTRPv2,BRD-K03911514,AAC,-0.00222133264863076,0.966754255149763,105,pan-cancer mRNA,GDSC1000,QL-XII-61,AAC,-0.001921372697901,0.96831027079988,585,pan-cancer mRNA,CTRPv2,NVP-BSK805,AAC,0.00134093696179376,0.968975348217829,512,pan-cancer mRNA,CTRPv2,blebbistatin,AAC,0.00286760434108107,0.969125325530744,83,pan-cancer mRNA,GDSC1000,AC220,AAC,0.00134512953326035,0.969322723797021,19,pan-cancer mRNA,CTRPv2,BRD-K14844214,AAC,-0.00144339177505145,0.970787647703004,113,pan-cancer mRNA,CTRPv2,lomeguatrib,AAC,-0.00132180871565358,0.971878687969521,426,pan-cancer mRNA,GDSC1000,RDEA119,AAC,0.00106474360265999,0.972563444132777,592,pan-cancer mRNA,FIMM,Bosutinib,AAC,-0.0139850730140896,0.972760250614056,93,pan-cancer mRNA,CTRPv2,simvastatin,AAC,0.00122339709792395,0.975393814857704,639,pan-cancer mRNA,CTRPv2,piperlongumine:MST-312 (1:1 mol/mol),AAC,0.00106001612283988,0.976514706510554,563,pan-cancer mRNA,GDSC1000,TL-1-85,AAC,0.000873013583344701,0.977034729101229,695,pan-cancer mRNA,CCLE,Crizotinib,AAC,-0.00114075738127753,0.979914978377458,248,pan-cancer mRNA,CTRPv2,BRD-K94991378,AAC,0.000917919460131615,0.981514008524037,170,pan-cancer mRNA,CTRPv2,Bexarotene,AAC,0.000837494824839972,0.981757237610047,72,pan-cancer mRNA,FIMM,Erlotinib,AAC,-0.00422824408751004,0.98217395730567,287,pan-cancer mRNA,GDSC1000,VNLG/124,AAC,0.000680555555039201,0.983443613825916,723,pan-cancer mRNA,GDSC1000,THZ-2-102-1,AAC,-0.000631854596046107,0.983546088765409,687,pan-cancer mRNA,CTRPv2,NSC23766,AAC,-0.000646823160733324,0.985465187721951,499,pan-cancer mRNA,GDSC1000,TAE684,AAC,0.000877577212050207,0.98679300095534,669,pan-cancer mRNA,CTRPv2,sitagliptin,AAC,0.00115143072181056,0.987688156009796,641,pan-cancer mRNA,GDSC1000,paclitaxel,AAC,-0.000759917683811564,0.988083342605942,526,pan-cancer mRNA,UHNBreast,Erlotinib,AAC,0.00382478205807192,0.989646447882215,287,pan-cancer mRNA,GDSC1000,VX-11e,AAC,0.000376116268099518,0.991030528962559,729,pan-cancer mRNA,GDSC1000,SB590885,AAC,-0.000365782364161282,0.991103581949682,615,pan-cancer mRNA,CTRPv2,isoliquiritigenin,AAC,-0.000455208811385548,0.994497010116131,369,pan-cancer mRNA,CTRPv2,CAY10618,AAC,-0.000202960531700097,0.995423536063921,203,pan-cancer mRNA,CCLE,Nilotinib,AAC,0.000279874288458813,0.995483313860927,491,pan-cancer mRNA,GDSC1000,Genentech Cpd 10,AAC,0.000144949236852897,0.996340137000391,317,pan-cancer mRNA,GDSC1000,CH5424802,AAC,-0.000110721772835529,0.997410924488977,220,pan-cancer mRNA,CTRPv2,PLX4720,AAC,9.92952065478418e-05,0.997770640538827,569,pan-cancer